Last reviewed · How we verify
Birth dose hepatitis B vaccine
At a glance
| Generic name | Birth dose hepatitis B vaccine |
|---|---|
| Sponsor | University of North Carolina, Chapel Hill |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit (NA)
- The COMBAT HBV Feasibility Trial (PHASE4)
- Autonomous Methadone Delivery System by Nurses (NA)
- Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) (PHASE3)
- Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads (NA)
- Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine (PHASE4)
- Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule (NA)
- Tunatar da ni. The Immunization Reminder and Information SMS System (IRISS) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: